Valuation check: VNRX's profit margin is -698.51%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
VolitionRX (VNRX) currently reports a profit margin of -698.51% as of September 2026. That compares with -1554.31% in the prior-year period — up 55.1% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore VolitionRX's profit margin history and peer comparisons.
VolitionRX's profit margin increased from -1554.31% to -698.51% — a 55.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
VolitionRX's profit margin of -698.51% is lower than the Healthcare sector average of 17.63%. That is roughly 4062.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but VolitionRX's current -698.51% should be judged against Healthcare norms (sector average: 17.63%) and against VNRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -698.51%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for VolitionRX, and consider following VNRX for alerts when major investors trade the stock.